title: Supplementing monosodium glutamate to partial enteral nutrition slows gastric emptying in preterm pigs(1-3).
abstract: Emerging evidence suggests that free glutamate may play a functional role in modulating gastroduodenal motor function. We hypothesized that supplementing monosodium glutamate (MSG) to partial enteral nutrition stimulates gastric emptying in preterm pigs. Ten-day-old preterm, parenterally fed pigs received partial enteral nutrition (25%) as milk-based formula supplemented with MSG at 0, 1.7, 3.0, and 4.3 times the basal protein-bound glutamate intake (468 mg·kg(-1)·d(-1)) from d 4 to 8 of life (n = 5-8). Whole-body respiratory calorimetry and (13)C-octanoic acid breath tests were performed on d 4, 6, and 8. Body weight gain, stomach and intestinal weights, and arterial plasma glutamate and glutamine concentrations were not different among the MSG groups. Arterial plasma glutamate concentrations were significantly higher at birth than after 8 d of partial enteral nutrition. Also at d 8, the significant portal-arterial concentration difference in plasma glutamate was substantial (∼500 μmol/L) among all treatment groups, suggesting that there was substantial net intestinal glutamate absorption in preterm pigs. MSG supplementation dose-dependently increased gastric emptying time and decreased breath (13)CO2 enrichments, (13)CO2 production, percentage of (13)CO2 recovery/h, and cumulative percentage recovery of (13)C-octanoic acid. Circulating glucagon-like peptide-2 (GLP-2) concentration was significantly increased by MSG but was not associated with an increase in intestinal mucosal growth. In contrast to our hypothesis, our results suggest that adding MSG to partial enteral nutrition slows the gastric emptying rate, which may be associated with an inhibitory effect of increased circulating GLP-2.
authors: USDA/Agricultural Research Service Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
authors: Caroline
authors: C
authors: Bauchart-Thevret
authors: Barbara
authors: B
authors: Stoll
authors: Nancy M
authors: NM
authors: Benight
authors: Oluyinka
authors: O
authors: Olutoye
authors: David
authors: D
authors: Lazar
authors: Douglas G
authors: DG
authors: Burrin
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002210:Caprylates / Q000378:metabolism; D002245:Carbon Dioxide / Q000378:metabolism; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D004750:Enteral Nutrition; D005746:Gastric Emptying / Q000187:drug effects*; D053767:Glucagon-Like Peptide 2 / Q000378:metabolism; D018698:Glutamic Acid / Q000097:blood*; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000187:drug effects / Q000254:growth & development; D018529:Nutritional Support; D010288:Parenteral Nutrition; D047928:Premature Birth; D012970:Sodium Glutamate / Q000009:adverse effects / Q000494:pharmacology*; D013552:Swine
chemical_list: D002210:Caprylates; D053767:Glucagon-Like Peptide 2; D002245:Carbon Dioxide; D018698:Glutamic Acid; C031492:octanoic acid; D012970:Sodium Glutamate